Stockreport

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Orchestra BioMed Holdings, Inc. - Ordinary Shares  (OBIO) 
PDF Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, con [Read more]